COvid-19 REgistry on THROMBOSIS complications associated with hospitalizatio

• Conditions: I80; Phlebitis and thrombophlebitis

• Registration Number: DRKS00022277
• Lead Sponsor: niversitätsmedizin der Johannes Gutenberg-Universität

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-30
• Study Completion: 2021-05-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 2708

Inclusion Criteria

Hospitalized patients aged 18 years or older with a positive test for SARS-CoV2.

Exclusion Criteria

No exclusion criteria will be applied given the observational nature of this registry.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) Fatal or non-fatal VTE Events;<br>2) Fatal or non-fatal cardiovascular Events encompassing stroke and myocardial infarction; <br>3) All-cause death occurring during first hospitalization for COVID-19.

Secondary Outcome Measures

Name	Time	Method
1) Baseline prevalence of cardiovascular risk factors and use of specific medications (statins, ACE inhibitors);<br>2) Length of hospitalization;<br>3) Prevalent use of in-hospital thromboprophylaxis; <br>4) Course of laboratory biomarkers (D-dimer, troponin).